Flow diagram of patients enrolled in this study. (HBsAg, hepatitis B... | Download Scientific Diagram
![HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study](https://publinestorage.blob.core.windows.net/7e8ebc33-67e7-49c1-b918-7208a46107fd/jcth-6-025-g001.jpg)
HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study
![NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B | Scientific Reports NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep38778/MediaObjects/41598_2016_Article_BFsrep38778_Fig4_HTML.jpg)
NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B | Scientific Reports
Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B | PLOS ONE
![Frontiers | Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection Frontiers | Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection](https://www.frontiersin.org/files/MyHome%20Article%20Library/784172/784172_Thumb_400.jpg)
Frontiers | Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
![The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B | BMC Pediatrics | Full Text The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B | BMC Pediatrics | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12887-022-03482-0/MediaObjects/12887_2022_3482_Fig1_HTML.png)
The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B | BMC Pediatrics | Full Text
![A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China - ScienceDirect A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0166354221001534-gr5.jpg)
A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China - ScienceDirect
![Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study](https://f6publishing.blob.core.windows.net/edd7a4fb-1408-4727-b457-3ae49e0f504a/WJG-26-1525-g004.png)
Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study
![Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy | Signal Transduction and Targeted Therapy Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00776-0/MediaObjects/41392_2021_776_Figa_HTML.png)
Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy | Signal Transduction and Targeted Therapy
![Viruses | Free Full-Text | Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies Viruses | Free Full-Text | Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies](https://www.mdpi.com/viruses/viruses-13-01090/article_deploy/html/images/viruses-13-01090-g001-550.jpg)
Viruses | Free Full-Text | Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
![Vaccines | Free Full-Text | Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon Vaccines | Free Full-Text | Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon](https://www.mdpi.com/vaccines/vaccines-11-00962/article_deploy/html/images/vaccines-11-00962-g001.png)
Vaccines | Free Full-Text | Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon
![Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis | Scientific Reports Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep29605/MediaObjects/41598_2016_Article_BFsrep29605_Fig1_HTML.jpg)